Martingale Asset Management’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-32,296
Closed -$350K 783
2025
Q1
$350K Buy
+32,296
New +$325K 0.01% 661
2024
Q4
Sell
-49,042
Closed -$551K 764
2024
Q3
$551K Sell
49,042
-4,298
-8% -$45.7K 0.01% 608
2024
Q2
$533K Buy
53,340
+27,930
+110% +$284K 0.01% 583
2024
Q1
$292K Buy
+25,410
New +$216K 0.01% 713
2021
Q2
Sell
-9,445
Closed -$348K 821
2021
Q1
$348K Buy
9,445
+1,512
+19% +$53.4K ﹤0.01% 710
2020
Q4
$299K Buy
+7,933
New +$245K ﹤0.01% 746

Other funds holding AHCO

Martingale Asset Management's AHCO Position: Q2 2025 in Review

Martingale Asset Management sold out of AdaptHealth (AHCO) in Q2 2025, closing a stake of 32,296 shares — an estimated $350K sold.

Martingale Asset Management first reported a position in AHCO in Q4 2020 and held it in 6 quarters. The position peaked at $551K in Q3 2024. 218 funds tracked by Wall St. Rank hold AHCO as of Q2 2025.

  • Martingale Asset Management reported no remaining AdaptHealth position as of Q2 2025 after selling out during the quarter.
  • Martingale Asset Management sold 32,296 AdaptHealth shares in Q2 2025, an estimated $350K.
  • Martingale Asset Management first reported a position in AdaptHealth in Q4 2020 and held it in 6 quarters.
  • Martingale Asset Management's AdaptHealth position peaked at $551K in Q3 2024.
  • 218 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2025.

Based on Martingale Asset Management's 13F filing for Q2 2025, filed 11 Aug 2025.